Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Renal Cell × Azacitidine × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 52 Myelodysplastic Syndromes 17 Leukemia, Myelomonocytic, Chronic 7 Myeloproliferative Disorders 6 Leukemia 6 Leukemia, Biphenotypic, Acute 4 Hematologic Neoplasms 3 Anemia, Refractory, with Excess of Blasts 3 Recurrence 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic-Myeloproliferative Diseases 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Hematologic Diseases 2 Thrombocytosis 1 Thrombocythemia, Essential 1 Sarcoma, Myeloid 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1

Interventions

Nivolumab 19 cabozantinib 14 Magnetic Resonance Spectroscopy 14 pembrolizumab 12 Specimen Handling 12 Ipilimumab 12 lenvatinib 5 Biopsy 5 atezolizumab 4 Immunoglobulin G 4 Everolimus 4 CTLA-4 Antigen 4 Axitinib 4 pazopanib 3 cemiplimab 3 Disulfides 3 Bevacizumab 3 zimberelimab 2 toripalimab 2 tivozanib 2 spartalizumab 2 belzutifan 2 avelumab 2 aldesleukin 2 aflibercept 2 Watchful Waiting 2 Pluvicto 2 Nephrectomy 2 IFL protocol 2 trastuzumab deruxtecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡